Presentations

Haile, Colin, et al.; Effects of FEN-γ€–CRMγ€—^197 conjugate vaccine + dmLT adjuvant with and without buprenorphine on fentanyl nociception in male and female Sprague Dawley rats, Military Health Systems Research Symposium. 2020 August.

Verrico, Christopher, et al.; Pharmacodynamic Interaction Between the Glucocorticoid Receptor Antagonist, PT150, and Ethanol in Healthy Veterans and Civilians, Military Health Systems Research Symposium. 2020 August. 

Verrico, Christopher; Pharmacotherapies for Alcohol and Substance Abuse Consortium. A Phase 1 Clinical Trial to Evaluate Pharmacodynamic Interactions after Oral Coadministration of Alcohol and the Highly Selective Glucocorticoid Receptor Antagonist, PT150. 2019 ACNP (American College of Neuropsychopharmacology). 2019 December.

Davis, Lori; Pilkinton, Patricia; Brackett, Stephen; Estes, Sandra; Brown, Ashley; McAlpine, Jessie; Sloup, Sharon; McCall, Kimberly; Leatherwood, Shaquela; Pharmacotherapies for Alcohol and Substance Abuse Consortium. Kappa Opioid Receptor Antagonism in the Treatment of Comorbid PTSD and Heavy Alcohol Use. VISN Research Summit. 2019 November.

Haile, Colin; Pharmacotherapies for Alcohol and Substance Abuse Consortium. Assessing Pharmacotherapies in Animal Models of Post-Traumatic Stress Disorder and Alcohol Use Disorder. MOMRP Substance Abuse & Violence Prevention IPR. 2019 September.

Verrico, Christopher; Pharmacotherapies for Alcohol and Substance Abuse Consortium. PT150 (formerly ORG 34517) as a Potential Treatment for Alcohol Use Disorder – Alcohol Interaction Study. MOMRP Substance Abuse & Violence Prevention IPR. 2019 September.

Pilkinton, Patricia; Pharmacotherapies for Alcohol and Substance Abuse Consortium. Novel Trial Design to Test Kappa Opioid receptor (KOR) Antagonism in the Treatment of Comorbid PTSD and Alcohol Use Disorder. Tuscaloosa VA Mental Health Summit. 2019 August.

Davis, Lori; Pharmacotherapies for Alcohol and Substance Abuse Consortium. It’s Time to HEAL: Help End Addiction Long-Term. Veteran Outreach at University of Alabama. 2019 July.

Haile, Colin; Pharmacotherapies for Alcohol and Substance Abuse Consortium. Novel Strategies for the Treatment of Opioid Use Disorder: Anti-fentanyl Vaccine. College on Problems of Drug Dependence, San Antonio, TX. 2019 June.

Bradley, Lauren; Innovative Application of the Jira Software Technology in the Clinical Trial Case Report Form Development Process. The Annual Meeting of the Society of Clinical Trials. 2019 May

Crawford, Meg; Bradley, Lauren; Calabro, Meghan; Nolen, Tracy; Williams, Rick; Surmounting Barriers with Targeted Solutions: Launching the Pharmacotherapies for Alcohol and Substance Abuse Consortium. The Annual Meeting of the Society of Clinical Trials. 2019 May.

Davis, Lori; Pharmacotherapies for Alcohol and Substance Abuse Consortium. Novel Trial Design to Test
Kappa Opioid Receptor (KOR) Antagonism in the Treatment of Comorbid PTSD and Alcohol Use Disorder. American Society of Clinical Psychopharmacology. 2019 May.

Becker, Howard; Pharmacotherapies for Alcohol and Substance Abuse Consortium. Preclinical Analysis of Combined Zonisamide and Doxazosin Treatments in a Stress-Alcohol Drinking Model. MOMRP Substance Abuse & Violence Prevention IPR. 2018 September. Society for Clinical Trials.